Juliana Alvares

Av. Presidente Antônio Carlos, 6627
Belo Horizonte, MG 31270901, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Indicator of access to medicines in relation to the multiple dimensions of access.

Indicator of access to medicines in relation to the multiple dimensions of access.

Journal: Journal of comparative effectiveness research

Published: September 13, 2019

Statin use in Brazil: findings and implications.

Statin use in Brazil: findings and implications.

Journal: Current medical research and opinion

Published: March 13, 2018

Effectiveness and safety of insulin glargine versus detemir analysis in patients with type 1 diabetes: systematic review and meta-analysis.

Effectiveness and safety of insulin glargine versus detemir analysis in patients with type 1 diabetes: systematic review and meta-analysis.

Journal: Therapeutic advances in endocrinology and metabolism

Published: January 14, 2018

Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications.

Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications.

Journal: The patient

Published: January 12, 2018

The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil.

The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil.

Journal: PharmacoEconomics

Published: November 16, 2017

The clinical effectiveness of insulin glargine in patients with Type I diabetes in Brazil: findings and implications.

The clinical effectiveness of insulin glargine in patients with Type I diabetes in Brazil: findings and implications.

Journal: Journal of comparative effectiveness research

Published: September 30, 2017

The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil.

The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil.

Journal: PloS one

Published: September 21, 2017

HEALTH TECHNOLOGY PERFORMANCE ASSESSMENT: REAL-WORLD EVIDENCE FOR PUBLIC HEALTHCARE SUSTAINABILITY.

HEALTH TECHNOLOGY PERFORMANCE ASSESSMENT: REAL-WORLD EVIDENCE FOR PUBLIC HEALTHCARE SUSTAINABILITY.

Journal: International journal of technology assessment in health care

Published: June 24, 2017

Pharmaceutical services in primary health care: interfederative agreement in the development of pharmaceutical policies in the Brazilian Unified Health System (SUS).

Pharmaceutical services in primary health care: interfederative agreement in the development of pharmaceutical policies in the Brazilian Unified Health System (SUS).

Journal: Revista de saude publica

Published: March 20, 2017

Consumer Willingness to Pay for Dengue Vaccine (CYD-TDV, Dengvaxia®) in Brazil; Implications for Future Pricing Considerations.

Consumer Willingness to Pay for Dengue Vaccine (CYD-TDV, Dengvaxia®) in Brazil; Implications for Future Pricing Considerations.

Journal: Frontiers in pharmacology

Published: November 22, 2016

Comparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System.

Comparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System.

Journal: Journal of comparative effectiveness research

Published: September 20, 2016

Patient satisfaction with pharmaceutical services in Brazilian primary health care.

Patient satisfaction with pharmaceutical services in Brazilian primary health care.

Journal: Revista de saude publica

Published: July 04, 2016

Showing 1-12 of 38

Last Updated: 09/26/2026